Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-30 |
filingDate |
2005-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45bf9c517a011e98be79175ac366d77d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d3ed68ef1a72f74b2e22bf197134f16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_053fbae343be2e37004bdbc6a67338fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b0f98e7ddaf1af316ab0d0b3806039 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7873862e2ed19e057af566f9f7df90ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_020a19efa5e34da61c082062674c66d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa41246d99728d530fc1a296162bc5ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a5b5ff3c8410fe37aef0967d848e2fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2882871fdccbc1cd78a3abb0e9b091cf |
publicationDate |
2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1807408-B1 |
titleOfInvention |
Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents |
priorityDate |
2004-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |